Ask Us
Please correct the highlighted fields below.

Alerts for Insulin Glargine

Title Date Published Source
Sanofi-aventis US, Inc. Recalls Several Lots of Lantus 2012-02-02
The FDA Issues Drug Safety Communication: Update to Ongoing Safety Review of Lantus (Insulin Glargine) and Possible Risk of Cancer 2011-01-16
Recall of GlucoPro Insulin Syringes 2010-01-26
Recall of All Accusure Insulin Syringes 2009-10-28
Recall of Two Lots of Accusure Insulin Syringes 2009-08-26
FDA Early Communication About Safety of Lantus (Insulin Glargine) 2009-07-01
Early Research Results About Possible Safety Issue With Insulin Glargine (Lantus) 2009-06-30
Insulin Pens and Insulin Cartridges Must Not Be Shared 2009-03-20
Recall of Single Lot of ReliOn Syringes 2008-11-06

See alerts for all drugs

Tell a friend

DISCLAIMER: MediGuard is not intended to be a substitute for professional medical advice. MediGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the MediGuard site and its content is at your own risk. The MediGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

Popular Terms: Lisinopril Side Effects, Plavix Side Effects, Copaxone Information, Metformin, Methotrexate Interactions

HACKER SAFE certified sites prevent over 99.9% of hacker crime.